Why would the SEC question pphm for a routine event (the non-proportional dilution of authorized in a RS) that they disclosed to shareholders. There is 0 reason to believe pphm is in negotiations with and Big Pharma.so no the SEC will not be talking to imiginary parties. But interesting, the letter now is to get the SEC to probe pphm. If that's the case, why not have them look at the bod setup. I would say that is much more an sec/nasdaq matter given their self-dealing and anti-shareholder actions.